ASHLEY VON DOHLEN: Open Payments
NPI 1710139613 · NEWTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$832 in 40 payments from 11 companies in 2025. Trend: 2023 $298 · 2024 $724 · 2025 $832
Food & beverage: $832
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $258 |
| Exact Sciences Corporation | 7 | $171 |
| AstraZeneca Pharmaceuticals LP | 6 | $100 |
| Bausch Health US, LLC | 3 | $64 |
| Lilly USA, LLC | 3 | $58 |
| ABBVIE INC. | 3 | $51 |
| ALK-Abello, Inc | 2 | $51 |
| MEDICOMP INC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
Products named: The Cologuard Plus Collection Kit, Wegovy, APLENZIN, MOUNJARO, AIRSUPRA, VRAYLAR, NEFFY, FARXIGA.
Industry payments across PA — which companies pay providers there.
